open access

Vol 81, No 8 (2010)
ARTICLES
Get Citation

MMP-1 and MMp-3 gene encoding polymorphism and the risk of the development of pelvic organ prolapse and stress urinary incontinence

Paweł Skorupski, Paweł Miotła, Katarzyna Jankiewicz, Tomasz Rechberger
Ginekol Pol 2010;81(8).

open access

Vol 81, No 8 (2010)
ARTICLES

Abstract

Abstract Objectives: The estimation of the association between the polymorphism at position -1607/1608 of the gene promoter encoding matrix metalloproteinase type 1 (MMP-1) and the polymorphism at position -1612/1617 of the gene promoter encoding stromelysin type 1 (MMP-3) and the risk of the occurrence of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Material and methods: 347 women were included into the analysis. POP study: the study group consisted of patients with clinically significant POP (POP-Q scale: 2, 3, 4). Women with normal pelvic floor statics (POP-Q scale: 0, 1) and not reporting symptoms of urinary incontinence were included into the control group. SUI study: the study group – patients with symptoms of stress urinary incontinence, the control group – continent women with normal pelvic floor statics (POP-Q scale: 0, 1). Samples of DNA were isolated from whole blood. The type of polymorphism was detected by RFLP method. Results: Both, in the POP and the SUI study, we have observed no statistically significant differences in the occurrences of MMP-1 and MMP-3 promoter polymorphisms between the study and the control groups. Also, the presence of the alleles G/GG (MMP-1) or 5A/6A (MMP-3) did not modify the risk of the POP and SUI development. Conclusions: Polymorphism type G/GG of gene promoter encoding MMP-1 and polymorphism type 5A/6A of the gene promoter encoding MMP-3 are not associated with the risk of the development of POP and SUI.

Abstract

Abstract Objectives: The estimation of the association between the polymorphism at position -1607/1608 of the gene promoter encoding matrix metalloproteinase type 1 (MMP-1) and the polymorphism at position -1612/1617 of the gene promoter encoding stromelysin type 1 (MMP-3) and the risk of the occurrence of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Material and methods: 347 women were included into the analysis. POP study: the study group consisted of patients with clinically significant POP (POP-Q scale: 2, 3, 4). Women with normal pelvic floor statics (POP-Q scale: 0, 1) and not reporting symptoms of urinary incontinence were included into the control group. SUI study: the study group – patients with symptoms of stress urinary incontinence, the control group – continent women with normal pelvic floor statics (POP-Q scale: 0, 1). Samples of DNA were isolated from whole blood. The type of polymorphism was detected by RFLP method. Results: Both, in the POP and the SUI study, we have observed no statistically significant differences in the occurrences of MMP-1 and MMP-3 promoter polymorphisms between the study and the control groups. Also, the presence of the alleles G/GG (MMP-1) or 5A/6A (MMP-3) did not modify the risk of the POP and SUI development. Conclusions: Polymorphism type G/GG of gene promoter encoding MMP-1 and polymorphism type 5A/6A of the gene promoter encoding MMP-3 are not associated with the risk of the development of POP and SUI.
Get Citation

Keywords

MMP-1, MMP-3, Stress urinary incontinence, Pelvic organ prolapse, Polymorphism

About this article
Title

MMP-1 and MMp-3 gene encoding polymorphism and the risk of the development of pelvic organ prolapse and stress urinary incontinence

Journal

Ginekologia Polska

Issue

Vol 81, No 8 (2010)

Bibliographic record

Ginekol Pol 2010;81(8).

Keywords

MMP-1
MMP-3
Stress urinary incontinence
Pelvic organ prolapse
Polymorphism

Authors

Paweł Skorupski
Paweł Miotła
Katarzyna Jankiewicz
Tomasz Rechberger

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl